Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
BACKGROUND: Antiglobulin responses are a significant limitation to the repeated use of murine monoclonal antibodies for treatment of transplant rejection. It is hoped that these might be largely overcome by using antibodies genetically engineered to resemble human antibodies. METHODS: We have compa...
Main Authors: | Rebello, P, Hale, G, Friend, P, Cobbold, S, Waldmann, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
Similar Items
-
Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
by: Friend, P, et al.
Published: (1991) -
Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
by: Tighe, H, et al.
Published: (1988) -
Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
by: Waldmann, H, et al.
Published: (1985) -
RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
by: Waldmann, H, et al.
Published: (1985) -
CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994)